Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
663
-
Total 13F shares, excl. options
-
43.9M
-
Shares change
-
+536K
-
Total reported value, excl. options
-
$15.5B
-
Value change
-
+$188M
-
Put/Call ratio
-
0.85
-
Number of buys
-
332
-
Number of sells
-
-253
-
Price
-
$352.84
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2024
735 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2024.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 663 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.9M shares
of 44.8M outstanding shares and own 98.05% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.36M shares), VANGUARD GROUP INC (4.44M shares), Avoro Capital Advisors LLC (2.76M shares), WELLINGTON MANAGEMENT GROUP LLP (2.46M shares), STATE STREET CORP (2.2M shares), RENAISSANCE TECHNOLOGIES LLC (2.09M shares), FMR LLC (1.47M shares), GEODE CAPITAL MANAGEMENT, LLC (1.14M shares), AQR CAPITAL MANAGEMENT LLC (975K shares), and LSV ASSET MANAGEMENT (909K shares).
This table shows the top 663 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.